Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-20-000007
Filing Date
2020-01-29
Accepted
2020-01-29 09:13:31
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 6-K a200129-6k.htm 6-K 18419
2 99.1 FINANCIAL REPORT Q4 2019 a200129-99_1.htm EX-99 443235
3 99.2 INTERIM FINANCIAL REPORT a200129-99_2.htm EX-99 2465934
4 IMAGE logo.jpg GRAPHIC 26773
  Complete submission text file 0001370368-20-000007.txt   2965258
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 20556548
SIC: 2834 Pharmaceutical Preparations